New Quest Alzheimer’s blood test can help clinical trial sponsors identify patients easily
The tests could prove useful in screening patients that coud benefit from therapies being tested for Alzheimer’s. But uptake will depend, in part, on reimbursement, according to doctors surveyed by Quest.
